Patient Perspectives on the Safety of Psilocybin-Assisted Psychotherapy for Bipolar Depression
About the Study
We are conducting research to understand patients’ perspectives on Psilocybin-Assisted Psychotherapy (PAP) as a treatment for bipolar depression. Psilocybin has shown promise in recent studies for treating unipolar depression, and we’re interested in learning how people living with bipolar disorder feel about it.
Who Can Participate?
- Aged 18 or older
- Diagnosed with bipolar disorder by a doctor,
- Currently living in Australia.
What’s Involved?
Completing an online survey that takes approximately 20–30 minutes.
The survey will cover:
- Questions about your experience with bipolar disorder.
- Your thoughts on current treatments.
- Your views on psilocybin-assisted psychotherapy (PAP).
Participation is anonymous—no personal information will be collected.
Please click the link below to start the survey: